{"id":630003,"date":"2024-10-04T15:43:45","date_gmt":"2024-10-04T19:43:45","guid":{"rendered":"https:\/\/www.singlecare.com\/blog\/?p=630003"},"modified":"2025-02-19T15:48:12","modified_gmt":"2025-02-19T20:48:12","slug":"wegovy-for-insulin-resistance","status":"publish","type":"post","link":"https:\/\/www.singlecare.com\/blog\/wegovy-for-insulin-resistance\/","title":{"rendered":"Does Wegovy help with insulin resistance?"},"content":{"rendered":"

Many people struggle with managing blood sugar levels and dealing with excess weight. If you\u2019re in this situation, you might feel frustrated and worried about developing <\/span>Type 2 diabetes<\/span><\/a>. This double burden isn’t just exhausting; it may also be harmful to your health.\u00a0<\/span><\/p>\n

A healthcare provider might suggest a medication like Wegovy (semaglutide) to manage these problems. Wegovy is known for promoting weight loss, which can also improve <\/span>insulin resistance<\/span><\/a> and overall metabolic health. Therefore, it may be an attractive option for those looking to lose weight and reduce the risk of diabetes.\u00a0<\/span><\/p>\n

What is insulin resistance?<\/span><\/h2>\n

Insulin resistance occurs when the body’s cells don\u2019t respond effectively to insulin, a hormone produced by the pancreas. This hormone helps cells absorb glucose (sugar) from the blood to use for energy. When cells resist insulin, glucose remains in the bloodstream, leading to <\/span>higher blood sugar levels<\/span><\/a>.<\/span><\/p>\n

GLP-1 receptors are also involved in the body’s response to insulin. They help increase insulin secretion from the pancreas and decrease glucose production in the liver.<\/span><\/p>\n

Risk factors for insulin resistance<\/span><\/a> include obesity and a family history of diabetes. Excess body weight, particularly around the stomach area, may contribute to insulin resistance by increasing inflammation in the body. In addition, a sedentary lifestyle can worsen these effects.\u00a0<\/span><\/p>\n

This condition can result in Type 2 diabetes if left unmanaged. Before reaching the diabetes stage, people may experience <\/span>prediabetes<\/span><\/a>, in which blood sugar levels are higher than normal but not high enough to be diagnosed as diabetes. Insulin resistance can also lead to other health issues, including heart disease and high blood pressure.<\/span><\/p>\n

RELATED: <\/b>Can you take Ozempic for prediabetes?<\/b><\/a><\/p>\n

Benefits of Wegovy for managing insulin resistance<\/span><\/h2>\n

Wegovy, developed by Novo Nordisk, contains the active ingredient semaglutide. It’s a <\/span>GLP-1 agonist<\/span><\/a>, which mimics the glucagon-like peptide-1 hormone. It works by reducing appetite, thus leading to weight loss, which may help improve insulin sensitivity.<\/span><\/p>\n

The Food and Drug Administration (FDA) has <\/span>approved Wegovy for weight loss<\/span><\/a> in adults and children 12 and older with obesity. It is also approved for adults who are overweight and have at least one weight-related condition, such as high blood pressure, Type 2 diabetes, or high cholesterol.<\/span><\/p>\n

Since the FDA has not approved Wegovy specifically for insulin resistance, using it for this purpose would be considered <\/span>off-label<\/span><\/a>.<\/span><\/p>\n

Improved insulin sensitivity<\/span><\/h3>\n

By promoting weight loss, Wegovy helps the body’s cells respond better to insulin, which can help manage blood sugar levels more effectively. This improved sensitivity means that less insulin is needed to keep blood sugar levels stable, making it easier for individuals to maintain healthy glucose levels.<\/span><\/p>\n

Reduced risk of heart disease<\/span><\/h3>\n

Losing weight may <\/span>decrease cholesterol levels<\/span><\/a>, reducing the risk of heart attacks and heart disease. Additionally, weight loss may help lower blood pressure, another important factor in heart health.<\/span><\/p>\n

Appetite control<\/span><\/h3>\n

As a GLP-1 agonist, Wegovy helps control food cravings, making it easier for individuals to stick to healthy eating habits. This control over appetite can lead to healthier food choices and better portion sizes, further supporting weight loss efforts.<\/span><\/p>\n

The extent to which Wegovy may help with weight loss can vary from person to person. However, research indicates that those using Wegovy can experience an average weight loss of <\/span>about 15%<\/span><\/a> after a year of treatment.<\/span><\/p>\n

Keep in mind that Wegovy’s active ingredient, semaglutide, is found under a different brand name, <\/span>Ozempic<\/span><\/a>. It is given at a slightly lower dosage than Wegovy and is FDA approved for Type 2 diabetes in adults. Ozempic is also approved to lower the risk of serious heart problems, like heart attack and stroke, for people with diabetes and heart disease.<\/span><\/p>\n

RELATED: <\/b>Wegovy vs. Ozempic<\/b><\/a><\/p>\n

Decreased blood sugar levels<\/span><\/h3>\n

Regular use of Wegovy can result in steadier and lower blood sugar levels, which is key for those with Type 2 diabetes. Consistent blood sugar levels help prevent the complications associated with diabetes, such as nerve damage and kidney problems.<\/span><\/p>\n

Dosage and usage of Wegovy for insulin resistance<\/span><\/h2>\n

Wegovy is taken as a weekly injection, which can be done at home after receiving training from a healthcare professional. It comes in a prefilled pen that makes it easy to use. The injection is typically given in the stomach area, thigh, or upper arm.<\/span><\/p>\n

RELATED: <\/b>Taking Wegovy for the first time<\/b><\/a><\/p>\n

There is no dosage specifically for insulin resistance, as it\u2019s approved as a weight-loss drug. A healthcare provider will need to determine the most appropriate dosage for insulin resistance.<\/span><\/p>\n

For chronic weight management, this medication is typically started at a lower dose and gradually increased to a standard dose over several weeks. For example, treatment typically begins with a dose of 0.25 mg once a week for the first four weeks, then increases to 0.5 mg for the next four weeks. <\/span>Dosages may be increased<\/span><\/a> until the standard dosage of 2.4 mg once a week is reached.\u00a0<\/span><\/p>\n

RELATED: <\/b>How quickly does Wegovy work?<\/b><\/a><\/p>\n

Other usage instructions:<\/span><\/p>\n